Mark S. Gelder MD

Insider Reports History

Location
Redwood City, CA
Signature
/s/ Mark Guerin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark S. Gelder MD:

Company Role Class Num Shares Value Price $ Report Date Ownership
Onconova Therapeutics, Inc. CHIEF MEDICAL OFFICER Restricted Stock Units 20,667 $13,847 $0.6700 13 Mar 2023 Direct
Onconova Therapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (right to purchase) 62,000 13 Mar 2023 Direct

Insider Reports Filed by Mark S. Gelder MD

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRAW Onconova Therapeutics, Inc. 13 Mar 2023 2 $0 4 CHIEF MEDICAL OFFICER 14 Mar 2023, 18:46
TRAW Onconova Therapeutics, Inc. 07 Feb 2023 3 -$1,689 4 CHIEF MEDICAL OFFICER 08 Feb 2023, 16:58
TRAW Onconova Therapeutics, Inc. 02 Aug 2022 3 -$1,498 4 CHIEF MEDICAL OFFICER 04 Aug 2022, 16:34
TRAW Onconova Therapeutics, Inc. 07 Feb 2022 2 $0 4 Chief Medical Officer 09 Feb 2022, 15:52
TRAW Onconova Therapeutics, Inc. 28 Sep 2021 1 +$10,000 4 Chief Medical Officer 29 Sep 2021, 08:25
TRAW Onconova Therapeutics, Inc. 02 Aug 2021 2 $0 4 Chief Medical Officer 04 Aug 2021, 20:02
TRAW Onconova Therapeutics, Inc. 14 Jun 2021 1 $0 4 Chief Medical Officer 17 Jun 2021, 19:46
TRAW Onconova Therapeutics, Inc. 14 Jun 2021 0 $0 3 Chief Medical Officer 17 Jun 2021, 19:42